| Literature DB >> 24273493 |
Anna Kiryk1, Katharina Sowodniok, Grzegorz Kreiner, Jan Rodriguez-Parkitna, Aynur Sönmez, Tomasz Górkiewicz, Holger Bierhoff, Marcin Wawrzyniak, Artur K Janusz, Birgit Liss, Witold Konopka, Günther Schütz, Leszek Kaczmarek, Rosanna Parlato.
Abstract
Decreased rRNA synthesis and nucleolar disruption, known as nucleolar stress, are primary signs of cellular stress associated with aging and neurodegenerative disorders. Silencing of rDNA occurs during early stages of Alzheimer's disease (AD) and may play a role in dementia. Moreover, aberrant regulation of the protein synthesis machinery is present in the brain of suicide victims and implicates the epigenetic modulation of rRNA. Recently, we developed unique mouse models characterized by nucleolar stress in neurons. We inhibited RNA polymerase I by genetic ablation of the basal transcription factor TIF-IA in adult hippocampal neurons. Nucleolar stress resulted in progressive neurodegeneration, although with a differential vulnerability within the CA1, CA3, and dentate gyrus (DG). Here, we investigate the consequences of nucleolar stress on learning and memory. The mutant mice show normal performance in the Morris water maze and in other behavioral tests, suggesting the activation of adaptive mechanisms. In fact, we observe a significantly enhanced learning and re-learning corresponding to the initial inhibition of rRNA transcription. This phenomenon is accompanied by aberrant synaptic plasticity. By the analysis of nucleolar function and integrity, we find that the synthesis of rRNA is later restored. Gene expression profiling shows that 36 transcripts are differentially expressed in comparison to the control group in absence of neurodegeneration. Additionally, we observe a significant enrichment of the putative serum response factor (SRF) binding sites in the promoters of the genes with changed expression, indicating potential adaptive mechanisms mediated by the mitogen-activated protein kinase pathway. In the DG a neurogenetic response might compensate the initial molecular deficits. These results underscore the role of nucleolar stress in neuronal homeostasis and open a new ground for therapeutic strategies aiming at preserving neuronal function.Entities:
Keywords: hippocampus; learning and memory; mTOR; neurogenesis; nucleolus; rRNA
Year: 2013 PMID: 24273493 PMCID: PMC3823236 DOI: 10.3389/fncel.2013.00207
Source DB: PubMed Journal: Front Cell Neurosci ISSN: 1662-5102 Impact factor: 5.505
Figure 1Conditional ablation of TIF-IA reduces 47S pre-rRNA level in the hippocampus. (A) TIF-IA and GAPDH mRNA and pre-rRNA decrease by qPCR in the hippocampi of control and TIF-IACaMKCreERT2 mutants 1 month after tamoxifen. (B) Upper panels: Representative images showing the specific effects of TIF-IA loss on pre-rRNA synthesis (blue staining) in CA1 and DG by in situ hybridization in coronal paraffin sections of control and TIF-IACaMKCreERT2 mutant mice 1 month after tamoxifen. Lower panels: TIF-IA protein analyzed by immunohistochemistry (IHC) in CA1 is visible in the nucleoli of controls but not in TIF-IACaMKCreERT2 mutant mice. (C) 18S rRNA analyzed by qPCR in control and TIF-IACaMKCreERT2 mutants 1 month after tamoxifen is not affected; n = 5. Error bars represent SEM. Scale bar: (B) upper panels: 150 μm; (B) lower panels: 60 μm. *p < 0.05; **p < 0.01.
Figure 2Hippocampal neurons survive in DG and CA1 of TIF-IA Representative images of IHC with NeuN specific antibody in DG and CA1 of control and TIF-IACaMKCreERT2 mutant mice 8 months after tamoxifen. (B) Quantification of DG area per section (% of control) in control and TIF-IACaMKCreERT2 mutant mice 1 and 8 months after tamoxifen. (C) Quantification of CA1 thickness (% of control) in control and TIF-IACaMKCreERT2 mutant mice 1 and 8 months after tamoxifen; n = 5. Error bars represent SEM. Scale bar: 120 μm. *p < 0.05.
Figure 3Nucleolar integrity is altered in CA1 and DG of TIF-IA. Representative images of IHC with the nucleolar markers nuclephosmin (NPM/B23) and nucleolin (NCL) in control and TIF-IACaMKCreERT2 mutant mice 1 month after tamoxifen showing reduced intensity of nucleolar staining of both proteins in the mutants. Scale bar: 60 μm.
Figure 4Nucleolar integrity is restored in CA1 and DG of TIF-IA. Representative images of IHC with the nucleolar markers nuclephosmin (NPM/B23) in control and TIF-IACaMKCreERT2 mutant mice 3 months after tamoxifen showing reduced intensity of nucleolar staining and re-localization to the nucleoplasm in the CA1 and mostly DG of mutants. Five months after tamoxifen TIF-IACaMKCreERT2 show intense staining of NPM/B23 in the nucleoli. Scale bar: 60 μm.
Figure 5pre-rRNA is restored in CA1 and DG of TIF-IA. Representative images of in situ hybridization performed in control and TIF-IACaMKCreERT2 mutant mice 3 and 5 months after tamoxifen. Three months after tamoxifen TIF-IACaMKCreERT2 mutant mice show loss of pre-rRNA in CA1 and DG in comparison to controls. Five months after tamoxifen TIF-IACaMKCreERT2 show intense pre-rRNA staining in the nucleoli. The sections were slightly counterstained with nuclear fast red. Scale bar: 60 μm.
Figure 6TIF-IA Tetanically induced LTP is lower in TIF-IACaMKCreERT2 mutant mice (open circles) in comparison with control group (filled circles) 1 month after tamoxifen. Arrows mark the stimulation (3 trains of 100 Hz, 1 s stimulation separated by 3 min; n = 5, control; n = 6, mutant). Each point represents the average of 5 min recording from each animal group ± SEM. Right panels: superimposed representative fEPSP traces recorded from control and TIF-IACaMKCreERT2 mutant mice 10 min before LTP induction (1 and 3, respectively) and 120 min after (2 and 4, respectively). Scale bars: 5 ms/2 mV. (B) Input-output (IO) curves representing the relationship between stimulus intensity and the slope of the fEPSP, did not differ significantly between control animals (filled circles; n = 5) and TIF-IACaMKCreERT2 mutant mice (open circles; n = 6). Right panels: representative fEPSP traces with maximal slope, recorded from control (upper panel) and TIF-IACaMKCreERT2 mutant mice (bottom panel). Scale bars: 5 ms/2 mV. (C) There were no differences in paired-pulse facilitation (PPF) ratios induced by delivering two stimuli with several different inter-stimulus intervals (15, 25, 35, 100, 150, and 200 ms) between control animals (filled circles; n = 5) and TIF-IACaMKCreERT2 mutant mice (open circles; n = 6). The PPF ratio represents the slope of the second fEPSP divided by the slope of the first fEPSP presented in %. (Right panels) Representative fEPSP traces evoked by two stimuli with the same intensity and inter-stimulus interval 15 ms, recorded from control (upper panel) and TIF-IACaMKCreERT2 mutant mice (bottom panel). Scale bars: 5 ms/2 mV.
Statistical analysis of the behavioral tests.
| Rotarod | Time to fall (s) | One-way ANOVA | One-way ANOVA | One-way ANOVA |
| Open field | Total distance moved (cm) | One-way ANOVA | One-way ANOVA | One-way ANOVA |
| Number of zones crossed | One-way ANOVA | One-way ANOVA | One-way ANOVA | |
| Velocity (cm/s) | One-way ANOVA | One-way ANOVA | One-way ANOVA | |
| Distance moved in subsequent minutes | ANOVA with repeated measures | ANOVA with repeated measures | ANOVA with repeated measures | |
| Elevated plus maze | Time (%) spent in zones of apparatus | One-way ANOVA | One-way ANOVA | One-way ANOVA |
| closed arms | closed arms | closed arms | ||
| open arms | open arms | open arms | ||
| Open field | Time (%) spent in center vs. periphery | One-way ANOVA | One-way ANOVA | One-way ANOVA |
| Visible platform test | Latency (s) | One-way ANOVA | One-way ANOVA | One-way ANOVA |
| Swim speed (cm/s) | One-way ANOVA | One-way ANOVA | One-way ANOVA | |
| Training to platform location 1, days 1–4 | Latency (s) | One-way ANOVA with repeated measures | One-way ANOVA with repeated measures | One-way ANOVA with repeated measures |
| Swim speed (cm/s) | One-way ANOVA with repeated measures | One-way ANOVA with repeated measures | One-way ANOVA with repeated measures | |
| Training to platform location 2 | Latency (s) | One-way ANOVA | One-way ANOVA | One-way ANOVA |
| Swim speed (cm/s) | One-way ANOVA | One-way ANOVA | One-way ANOVA | |
| Test 1 | Time in target zone (%) | One-way ANOVA | One-way ANOVA | One-way ANOVA |
| Test 2 | Test 2, time in target zone (%) | One-way ANOVA | One-way ANOVA | One-way ANOVA |
Figure 7TIF-IA Morris water maze procedure. Trials order in subsequent days. (B) Spatial learning in Morris water maze 5 weeks, 3 and 6 months after tamoxifen. Time to find a hidden platform in 4-day learning and 1-day re-learning is shown. Enhanced learning abilities in mutant compared to control mice (p < 0.05) were observed 5 weeks after induction of mutation. Deterioration in 1-day re-learning task was found in mutants 6 months after tamoxifen. No differences in swim speed were found. (C) Spatial memory tests in Morris water maze 5 weeks, 3 and 6 months after tamoxifen. Relative time of swimming in target quadrant (%) is shown. Memory tests performed 24 h (Test 1) as well as 48 h (Test 2) after the last training day, showed memory for platform location in control and mutant mice tested in each time points after induction of mutation. Randomness level (25%) is indicated by dotted line. *p < 0.05.
Analysis of gender differences in control and TIF-IA.
| Visible platform test | |||
| Control females | 14.09 | 3.53 | |
| Control males | 13.5 | 5 | |
| Mutant females | 12.81 | 6.49 | |
| Mutant males | 12.37 | 9.64 | |
| Control females | 19.9 | 1.09 | |
| Control males | 20.45 | 0.56 | |
| Mutant females | 20.88 | 0.95 | |
| Mutant males | 18.54 | 0.59 | |
| Training to platform location 1, day 4 | |||
| Control females | 27.79 | 7.33 | |
| Control males | 15.74 | 2.06 | |
| Mutant females | 13.03 | 1.48 | |
| Mutant males | 11.72 | 1.21 | |
| Control females | 20.71 | 1.09 | |
| Control males | 21.25 | 0.56 | |
| Mutant females | 21.68 | 0.95 | |
| Mutant males | 19.34 | 0.59 | |
| Training to platform location 2 | |||
| Control females | 29.3 | 1.08 | |
| Control males | 33.99 | 3.076 | |
| Mutant females | 22.57 | 3.60 | |
| Mutant males | 27.71 | 2.49 | |
| Control females | 20.30 | 0.88 | |
| Control males | 21.64 | 0.83 | |
| Mutant females | 21.66 | 1.15 | |
| Mutant males | 19.18 | 0.67 | |
| Test 1 | |||
| Control females | 28.73 | 6.15 | |
| Control males | 44.38 | 5.76 | |
| Mutant females | 36.83 | 7.55 | |
| Mutant males | 45.03 | 3.19 | |
| Test 2 | |||
| Control females | 32.81 | 6.13 | |
| Control males | 32.15 | 4.07 | |
| Mutant females | 30.99 | 6.40 | |
| Mutant males | 30.73 | 3.66 | |
Figure 8Moderate effects on gene expression in TIF-IA. One month after tamoxifen treatment. (A) Identification of 36 transcripts at unadjusted p < 0.001 and their fold change vs. control group; (B) Heat map visualization of gene set enrichment analysis (GSEA) reveals changes in genes associated with vincristine resistance; (C) Identification of enriched putative transcription factor binding sites performed using cREMaG database.
Figure 9mTOR signaling is active in control and TIF-IA Representative images of the immunostaining with phospho-S6 (brown) and NeuN (green) antibodies in DG and CA1 on paraffin sections of control and TIF-IACaMKCreERT2 mutant mice 1 month after tamoxifen. (B) Quantification of phospho-S6 positive neurons 1 and 8 months after tamoxifen in DG (left panel) and CA1 (right pane); n = 5. Scale bar: 120 μm.
Figure 10Increased neurogenesis in TIF-IA Analysis of Ki67 positive cells in the DG 3 months after tamoxifen in controls and TIF-IACaMKCreERT2 mutants. (B) Representative images of doublecortin positive cells in the DG 3 months after tamoxifen. Hematoxylin counterstaining has been used to visualize the nuclei. (C) Control and mutant mice were injected for 5 days with BrdU 2.5 months after tamoxifen. Doublecortin (dcx) positive (brown) BrdU retaining (green) cells were counted 2 and 6 weeks after BrdU injections. (D) Quantification of Ki67 positive, and BrdU positive cells (2 h after single BrdU injection) 1 and 3 months after tamoxifen (upper panels). Quantification of the increased dcx positive cells shows significant increase 2 months after tamoxifen. Quantification of doublecortin positive cells retaining BrdU staining 2 and 6 weeks after BrdU injections shows significant increase in the TIF-IACaMKCreERT2 mutant mice (lower panels); n = 5–6. Scale bars: (A,B) 120 μm; (C) 60 μm. *p < 0.05; **p < 0.01.